Tamarly Intelligence

Who Holds Eloxx Pharmaceuticals, Inc. (ELOX)? 22 Institutional Holders, Q2 2026

Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 22 holders, $35 million in total.

Largest holders

The 22 largest by value. Change in shares against the quarter before.

ManagerSharesValueChange
Nantahala Capital Management, LLC400,000$6 millionNew13F
Siren, L.L.C.400,000$6 millionNew13F
Aberdeen Group plc400,000$6 millionNew13F
EcoR1 Capital, LLC400,000$6 millionNew13F
SAMSARA BIOCAPITAL, LLC400,000$6 millionNew13F
Stonepine Capital Management, LLC397,160$6 millionNew13F
VANGUARD CAPITAL MANAGEMENT LLC78,680$1 millionNew13F
VANGUARD FIDUCIARY TRUST CO10,602$147,156New13F
SEVEN GRAND MANAGERS, LLC10,000$138,800New13F
MORGAN STANLEY1,544$21,431New13F
Vanguard Global Advisers, LLC718$9,966New13F
UBS Group AG637$8,842New13F
WELLS FARGO & COMPANY/MN126$1,749New13F
Pioneer Family Office, LLC96$1,332New13F
ROYAL BANK OF CANADA98$1,000New13F
Altshuler Shaham Ltd25$347New13F
BARCLAYS PLC12$167New13F
Towne Trust Company, N.A5$69New13F
Activest Wealth Management4$56New13F
CITIGROUP INC4$56New13F
SBI Securities Co., Ltd.2$28New13F
Point Nemo Capital, LLC1$14New13F

Questions and answers

How many institutions hold Eloxx Pharmaceuticals, Inc.?
22 managers reported Eloxx Pharmaceuticals, Inc. on Form 13F for the quarter ended 30 June 2026.
Who is the largest institutional holder of Eloxx Pharmaceuticals, Inc.?
Nantahala Capital Management, LLC, with 400,000 shares worth $6 million on its 13F for Q2 2026.
How many institutions bought or sold out of Eloxx Pharmaceuticals, Inc. in Q2 2026?
22 managers reported a new position and 0 reported none after holding it the quarter before.
See every holder, the full history and an alert when the next 13F filings land; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Eloxx Pharmaceuticals, Inc., Q2 2026", https://app.tamarly.ai/holders/eloxx-pharmaceuticals, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Who Holds Eloxx Pharmaceuticals, Inc. (ELOX)? 22 Institutional Holders, Q2 2026 | Tamarly